As clinical research continues to evolve, the traditional model of requiring all participants to visit a centralized trial site is being challenged. In its place, decentralized clinical trials (DCTs) are emerging as a modern, patient-centered approach to research that expands access and improves participation. For both sponsors and participants in Florida, especially in diverse communities like South Florida, decentralized trials offer unique opportunities and benefits.

At South Florida Clinical Research Institute (SFCRI), we are actively embracing decentralized and hybrid trial models to meet the needs of today’s participants while maintaining scientific and regulatory rigor.

What Are Decentralized Clinical Trials?

A decentralized clinical trial is a study design that reduces the need for in-person visits to a central site. Instead, it leverages technology and community-based resources to allow for remote participation. These trials may involve:

  • Telehealth visits instead of in-clinic exams
  • Wearable devices or mobile apps to monitor health
  • Home delivery of study medications
  • Local labs or pharmacies for sample collection
  • Electronic informed consent (eConsent)

DCTs can be fully decentralized or hybrid, where some site visits are still required but others are virtual or done off-site. The key goal is to make participation more accessible without compromising data quality.

Why Decentralized Trials Matter in Florida

Florida’s unique demographics and geography make it an ideal environment for decentralized clinical trials:

  • Diverse patient population: With a mix of Hispanic/Latino, African American, and multilingual communities, Florida offers rich representation for sponsors.
  • Geographic spread: Decentralization makes it easier to include participants from rural or underserved areas without requiring long travel times.
  • Aging population: Older adults may face transportation or mobility challenges that DCTs help to overcome.

SFCRI, located in South Florida, is strategically positioned to recruit and retain diverse participants through both traditional and decentralized trial formats.

Benefits of Decentralized Clinical Trials for Participants

  • Convenience and Comfort: Participants can join from home, reducing time off work or travel expenses. This model is especially helpful for individuals with limited mobility or caregiving responsibilities.
  • Improved Access to Research: People who live far from clinical sites or in medically underserved areas now have greater access to innovative treatments.
  • Faster Participation: With digital tools and remote onboarding, enrollment can be faster and more streamlined.
  • Personalized Engagement: Apps and wearable devices allow patients to monitor their health and stay engaged with the research team in real-time.

By removing logistical barriers, decentralized clinical trials improve trial accessibility and inclusivity.

Advantages of Decentralized Trials for Sponsors and CROs

  • Broader Recruitment Reach: Decentralized models enable outreach to more representative populations across wider geographic areas, enhancing diversity in clinical trials.
  • Higher Retention Rates: Fewer site visits can lead to reduced participant burden, helping keep volunteers engaged throughout the trial — a key concern in trial retention.
  • Real-World Data (RWD): Wearables and EHR integration allow sponsors to gather continuous, real-world data, which complements traditional endpoints and offers deeper insights.
  • Operational Efficiency: Remote monitoring and electronic data collection reduce costs and streamline workflows, especially when combined with hybrid clinical trials.

SFCRI works closely with sponsors to design pragmatic and regulatory-compliant DCT models that maintain high data quality and GCP compliance.

Addressing Concerns: Data Security and Compliance

A common concern with decentralized clinical trials is data integrity and privacy. At SFCRI, we implement robust safeguards to ensure:

  • Secure EDC platforms for data collection
  • HIPAA-compliant telehealth systems
  • Rigorous SOPs for remote monitoring and auditing
  • Training for staff and participants in virtual trial protocols

Our decentralized workflows are designed with both trial accessibility and regulatory oversight in mind, ensuring that no compromises are made in participant protection.

The Role of Hybrid Clinical Trials

While some studies are fully decentralized, many adopt a hybrid model that combines virtual and on-site elements. Hybrid trials provide flexibility without losing the benefits of physical evaluations when needed.

For example, a participant might:

  • Complete screening and consent in-person
  • Attend follow-up visits via telemedicine
  • Submit biometric data through a wearable device

This blend offers the best of both worlds and is highly effective for therapeutic areas such as diabetes, cardiovascular disease, and women’s health — specialties that SFCRI frequently supports.

How SFCRI Supports Decentralized Trials

SFCRI is actively engaged in decentralized clinical trials in Florida, with capabilities that include:

  • Telehealth-ready staff and physicians
  • Remote patient onboarding and eConsent systems
  • Partnerships with local labs and imaging centers
  • Multilingual outreach teams to ensure inclusive recruitment
  • Remote monitoring technology integrated with our data systems

Sponsors and CROs benefit from our infrastructure and patient-first approach to research, whether the trial is fully remote, hybrid, or transitioning from traditional models.

Conclusion: The Future of Clinical Trials is Flexible

Decentralized clinical trials are reshaping how we think about clinical research — making it more inclusive, efficient, and participant-friendly. For both patients and sponsors in Florida, especially in communities like South Florida, this model removes long-standing barriers to participation.

SFCRI is proud to be a regional leader in deploying hybrid clinical trials, leveraging remote monitoring, telehealth, and community partnerships to deliver meaningful results without sacrificing quality or compliance.

Interested in running a decentralized trial in Florida? Contact SFCRI to learn how we can support your next study with innovative, accessible solutions.